Peter Sicinski, M.D., Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Peter Sicinski, M.D., Ph.D., Dana-Farber Cancer Institute

Caption

Peter Sicinski, M.D., Ph.D., and colleagues at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins that control cells' growth cycles, and to which the cancers are "addicted."

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.